GlucoTrack, Inc. (GCTK)
- Previous Close
0.4600 - Open
0.4789 - Bid 0.4560 x 100
- Ask 0.4729 x 100
- Day's Range
0.4521 - 0.4800 - 52 Week Range
0.1330 - 0.9900 - Volume
158,461 - Avg. Volume
180,834 - Market Cap (intraday)
12.182M - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
glucotrack.comRecent News: GCTK
Performance Overview: GCTK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GCTK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GCTK
Valuation Measures
Market Cap
12.18M
Enterprise Value
7.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.81
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-1.11
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-120.93%
Return on Equity (ttm)
-320.62%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-7.95M
Diluted EPS (ttm)
-0.3800
Balance Sheet and Cash Flow
Total Cash (mrq)
4.49M
Total Debt/Equity (mrq)
6.13%
Levered Free Cash Flow (ttm)
-3.9M